ANI Pharmaceuticals, Inc.
ANIP
$67.37
$0.01390.02%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 221.12M | 193.08M | 161.71M | 67.76M | 48.23M |
| Total Receivables | 162.08M | 178.84M | 172.93M | 174.71M | 165.44M |
| Inventory | 111.20M | 106.59M | 104.32M | 103.65M | 105.36M |
| Prepaid Expenses | 17.20M | 10.49M | 8.05M | 6.67M | 8.39M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.22M | 8.22M | 12.31M | 11.96M | 16.85M |
| Total Current Assets | 519.82M | 497.22M | 459.31M | 364.75M | 344.26M |
|
|
|||||
| Total Current Assets | 519.82M | 497.22M | 459.31M | 364.75M | 344.26M |
| Net Property, Plant & Equipment | 44.59M | 44.19M | 44.37M | 43.28M | 43.25M |
| Long-term Investments | 28.22M | 28.22M | 28.22M | 28.22M | 28.22M |
| Goodwill | 28.22M | 28.22M | 28.22M | 28.22M | 28.22M |
| Total Other Intangibles | 209.01M | 219.83M | 230.30M | 238.79M | 251.64M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.58M | 90.46M | 87.94M | 83.28M | 83.92M |
| Total Assets | 904.42M | 889.91M | 859.34M | 765.22M | 760.09M |
|
|
|||||
| Total Accounts Payable | 36.68M | 34.08M | 28.51M | 32.69M | 29.31M |
| Total Accrued Expenses | 56.28M | 43.45M | 38.69M | 35.42M | 35.89M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.41M | 850.00K | 850.00K | 850.00K | 850.00K |
| Total Finance Division Other Current Liabilities | 50.11M | 55.97M | 54.82M | 56.87M | 33.40M |
| Total Other Current Liabilities | 50.11M | 55.97M | 54.82M | 56.87M | 33.40M |
| Total Current Liabilities | 145.48M | 134.35M | 122.87M | 125.83M | 99.44M |
|
|
|||||
| Total Current Liabilities | 145.48M | 134.35M | 122.87M | 125.83M | 99.44M |
| Long-Term Debt | 284.82M | 285.03M | 285.24M | 285.46M | 285.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.11M | 5.26M | 4.73M | 1.20M | 1.38M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.42M | 10.56M | 12.03M | 13.26M | 35.06M |
| Total Liabilities | 446.82M | 435.20M | 424.87M | 425.74M | 421.55M |
|
|
|||||
| Common Stock & APIC | 514.11M | 506.52M | 495.49M | 408.40M | 403.90M |
| Retained Earnings | -80.13M | -80.88M | -90.41M | -96.25M | -97.29M |
| Treasury Stock & Other | -1.22M | 4.23M | 4.55M | 2.49M | 7.07M |
| Total Common Equity | 432.75M | 429.86M | 409.62M | 314.63M | 313.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
|
|
|||||
| Total Common Equity | 432.75M | 429.86M | 409.62M | 314.63M | 313.69M |
| Total Preferred Equity | 24.85M | 24.85M | 24.85M | 24.85M | 24.85M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 457.60M | 454.71M | 434.47M | 339.48M | 338.54M |
|
|
|||||
